Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10113
797
mi
from 43215
Metairie, LA
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10113
797
mi
from 43215
Metairie, LA
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 024
643
mi
from 43215
Boston, MA
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 024
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site CHACHAR
642
mi
from 43215
New Bedford, MA
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site CHACHAR
642
mi
from 43215
New Bedford, MA
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
1333
mi
from 43215
Albuquerque, NM
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
1333
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 1329
110
mi
from 43215
Akron, OH
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 1329
110
mi
from 43215
Akron, OH
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10132
2055
mi
from 43215
Eugene, OR
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10132
2055
mi
from 43215
Eugene, OR
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13218
417
mi
from 43215
Jenkintown, PA
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13218
417
mi
from 43215
Jenkintown, PA
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
174
mi
from 43215
Uniontown, PA
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
174
mi
from 43215
Uniontown, PA
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10487
896
mi
from 43215
Plano, TX
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10487
896
mi
from 43215
Plano, TX
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 66
164
mi
from 43215
Morgantown, WV
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 66
164
mi
from 43215
Morgantown, WV
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13632
1915
mi
from 43215
Redlands, CA
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13632
1915
mi
from 43215
Redlands, CA
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 1297
1153
mi
from 43215
Aurora, CO
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 1297
1153
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 038
1163
mi
from 43215
Englewood, CO
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 038
1163
mi
from 43215
Englewood, CO
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13071
503
mi
from 43215
Stamford, CT
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13071
503
mi
from 43215
Stamford, CT
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13635
861
mi
from 43215
Bradenton, FL
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13635
861
mi
from 43215
Bradenton, FL
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13616
837
mi
from 43215
Pinellas Park, FL
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13616
837
mi
from 43215
Pinellas Park, FL
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10345
mi
from 43215
Evanston, IL
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10345
mi
from 43215
Evanston, IL
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13618
711
mi
from 43215
Fremont, NE
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13618
711
mi
from 43215
Fremont, NE
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 60
1756
mi
from 43215
Las Vegas, NV
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 60
1756
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
1
mi
from 43215
Columbus, OH
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
1
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13625
113
mi
from 43215
Mogadore, OH
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13625
113
mi
from 43215
Mogadore, OH
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13615
350
mi
from 43215
Greer, SC
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13615
350
mi
from 43215
Greer, SC
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
911
mi
from 43215
Dallas, TX
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 005
1514
mi
from 43215
Murray, UT
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 005
1514
mi
from 43215
Murray, UT
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 46
437
mi
from 43215
Virginia Beach, VA
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 46
437
mi
from 43215
Virginia Beach, VA
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 11124
mi
from 43215
Hamilton,
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 11124
mi
from 43215
Hamilton,
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10552
394
mi
from 43215
Saint Louis, MO
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10552
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 12467
525
mi
from 43215
Mount Pleasant, SC
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 12467
525
mi
from 43215
Mount Pleasant, SC
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 12299
713
mi
from 43215
Gainesville, FL
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 12299
713
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 58
1715
mi
from 43215
Boise, ID
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 58
1715
mi
from 43215
Boise, ID
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 14747
337
mi
from 43215
Pikesville, MD
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 14747
337
mi
from 43215
Pikesville, MD
Click here to add this to my saved trials
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13575
444
mi
from 43215
Raritan, NJ
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) vs Placebo for the Preventive Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13575
444
mi
from 43215
Raritan, NJ
Click here to add this to my saved trials
Greater Occipital Nerve Block With Bupivacaine for Acute Migraine
A Randomized, Sham-controlled Trial of Greater Occipital Nerve Block as Second Line Therapy for ED Patients With Acute Migraine
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Greater Occipital Nerve Block With Bupivacaine for Acute Migraine
A Randomized, Sham-controlled Trial of Greater Occipital Nerve Block as Second Line Therapy for ED Patients With Acute Migraine
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Cognitive-Behavior Therapy for Posttraumatic Headache
Coalition to Alleviate PTSD: Randomized Clinical Trial of Cognitive-Behavior Therapy for Posttraumatic Headache
Status: Enrolling
Updated:  12/31/1969
San Antonio VA Medical Center
1138
mi
from 43215
San Antonio, TX
Cognitive-Behavior Therapy for Posttraumatic Headache
Coalition to Alleviate PTSD: Randomized Clinical Trial of Cognitive-Behavior Therapy for Posttraumatic Headache
Status: Enrolling
Updated: 12/31/1969
San Antonio VA Medical Center
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Metformin for the Prevention of Episodic Migraine (MPEM)
Metformin for the Prevention of Episodic Migraine: a Randomized, Double-blind, Placebo-controlled, Crossover Study
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Arizona
1645
mi
from 43215
Scottsdale, AZ
Metformin for the Prevention of Episodic Migraine (MPEM)
Metformin for the Prevention of Episodic Migraine: a Randomized, Double-blind, Placebo-controlled, Crossover Study
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Arizona
1645
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
HIRREM Developmental Study
Functional and Physiological Effects of High-resolution, Relational, Resonance-based, Electroencephalic Mirroring (HIRREM) for Neurological, Cardiovascular and Psychophysiological Disorders
Status: Enrolling
Updated:  12/31/1969
Department of Neurology, Wake Forest School of Medicine
306
mi
from 43215
Winston-Salem, NC
HIRREM Developmental Study
Functional and Physiological Effects of High-resolution, Relational, Resonance-based, Electroencephalic Mirroring (HIRREM) for Neurological, Cardiovascular and Psychophysiological Disorders
Status: Enrolling
Updated: 12/31/1969
Department of Neurology, Wake Forest School of Medicine
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Spectacle Tints and Thin-Films for Migraine
Spectacle Tints and Thin-Films to Reduce Headache Frequency in Patients With Chronic Migraine
Status: Enrolling
Updated:  12/31/1969
John A Moran Eye Center; University of Utah Hospitals and Clinics
1510
mi
from 43215
Salt Lake City, UT
Spectacle Tints and Thin-Films for Migraine
Spectacle Tints and Thin-Films to Reduce Headache Frequency in Patients With Chronic Migraine
Status: Enrolling
Updated: 12/31/1969
John A Moran Eye Center; University of Utah Hospitals and Clinics
1510
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Spectacle Tints and Thin-Films for Migraine
Spectacle Tints and Thin-Films to Reduce Headache Frequency in Patients With Chronic Migraine
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic
1650
mi
from 43215
Phoenix, AZ
Spectacle Tints and Thin-Films for Migraine
Spectacle Tints and Thin-Films to Reduce Headache Frequency in Patients With Chronic Migraine
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
1650
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Spectacle Tints and Thin-Films for Migraine
Spectacle Tints and Thin-Films to Reduce Headache Frequency in Patients With Chronic Migraine
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hospital; John R Graham Headache Center; Harvard University
639
mi
from 43215
Boston, MA
Spectacle Tints and Thin-Films for Migraine
Spectacle Tints and Thin-Films to Reduce Headache Frequency in Patients With Chronic Migraine
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hospital; John R Graham Headache Center; Harvard University
639
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Spectacle Tints and Thin-Films for Migraine
Spectacle Tints and Thin-Films to Reduce Headache Frequency in Patients With Chronic Migraine
Status: Enrolling
Updated:  12/31/1969
Headache Center of the Neuroscience Institute; Hofstra Northwell Health; Northshore University Hospital
492
mi
from 43215
Great Neck, NY
Spectacle Tints and Thin-Films for Migraine
Spectacle Tints and Thin-Films to Reduce Headache Frequency in Patients With Chronic Migraine
Status: Enrolling
Updated: 12/31/1969
Headache Center of the Neuroscience Institute; Hofstra Northwell Health; Northshore University Hospital
492
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated:  12/31/1969
Mile High Research Center
1161
mi
from 43215
Denver, CO
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated: 12/31/1969
Mile High Research Center
1161
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated:  12/31/1969
The New England Center for Headache
503
mi
from 43215
Stamford, CT
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated: 12/31/1969
The New England Center for Headache
503
mi
from 43215
Stamford, CT
Click here to add this to my saved trials
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated:  12/31/1969
Walton Rehabilitation Hospital
452
mi
from 43215
Augusta, GA
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated: 12/31/1969
Walton Rehabilitation Hospital
452
mi
from 43215
Augusta, GA
Click here to add this to my saved trials
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated:  12/31/1969
Rush Pain Center
274
mi
from 43215
Chicago, IL
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated: 12/31/1969
Rush Pain Center
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated:  12/31/1969
Diamond Headache Clinic
276
mi
from 43215
Chicago, IL
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated: 12/31/1969
Diamond Headache Clinic
276
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated:  12/31/1969
Headache Care Center
588
mi
from 43215
Springfield, MO
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated: 12/31/1969
Headache Care Center
588
mi
from 43215
Springfield, MO
Click here to add this to my saved trials
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated:  12/31/1969
Headache Specialists
1756
mi
from 43215
Las Vegas, NV
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated: 12/31/1969
Headache Specialists
1756
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated:  12/31/1969
Albert Einstein College of Medicine - Montefiore Headache Unit
482
mi
from 43215
Bronx, NY
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated: 12/31/1969
Albert Einstein College of Medicine - Montefiore Headache Unit
482
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated:  12/31/1969
The Neurological Clinic
2029
mi
from 43215
Portland, OR
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated: 12/31/1969
The Neurological Clinic
2029
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University - Jefferson Headache
416
mi
from 43215
Philadelphia, PA
Treatment for Migraines With an Implantable Device
Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University - Jefferson Headache
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials